SCHEMBL5213152

SCHEMBL5213152

COC(=O)c1cccc(OCc2ccccc2)c1CO

nearest known ligand 0.54

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SGMS2 Q8NHU3 3/20 0.51
PTGER1 P34995 1/20 0.50
NPC1 O15118 2/20 0.49
RAB9A P51151 2/20 0.49
HPGD P15428 2/20 0.49
SMN1; SMN2 Q16637 2/20 0.49
KDM4E B2RXH2 1/20 0.49
ALDH1A1 P00352 1/20 0.49
MEN1 O00255 3/20 0.49
KMT2A Q03164 3/20 0.49
HTT P42858 1/20 0.49
BRD4 O60885 1/20 0.49
LMNA P02545 2/20 0.48
MAPT P10636 2/20 0.48
L3MBTL1 Q9Y468 2/20 0.48
GAA P10253 1/20 0.48
MAPK1 P28482 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
NPSR1 Q6W5P4 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL978857 0.85 HTT (0.64) SGMS2PTGER1NPC1SMN1; SMN2ALDH1A1
SCHEMBL28399309 0.84 SGMS2 (0.47) SGMS2PTGER1NPC1RAB9AHPGD
SCHEMBL1305662 0.83 HPGD (0.57) SGMS2PTGER1NPC1RAB9AHPGD
SCHEMBL29930977 0.83 SGMS2 (0.54) SGMS2PTGER1NPC1RAB9AHPGD
SCHEMBL1097551 0.83 SGMS2 (0.54) SGMS2PTGER1NPC1RAB9AHPGD
SCHEMBL5940976 0.83 SGMS2 (0.54) SGMS2PTGER1NPC1RAB9AHPGD
SCHEMBL25720776 0.83 MAPT (0.63) SGMS2PTGER1NPC1RAB9AHPGD
SCHEMBL24072904 0.82 NPC1 (0.53) SGMS2PTGER1NPC1RAB9AHPGD
SCHEMBL29930885 0.82 NPC1 (0.60) SGMS2PTGER1NPC1RAB9AHPGD
SCHEMBL23611725 0.82 NPC1 (0.60) SGMS2PTGER1NPC1RAB9AHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1789399-A1 QUINAZOLINONE DERIVATIVES AND THEIR USE AS B-RAF INHIBITORS AstraZeneca AB (SE) 2007-05-30 EP disclosed
EP-1765790-A1 AZINE-CARBOXAMIDES AS ANTI-CANCER AGENT AstraZeneca AB (SE) 2007-03-28 EP disclosed
WO-2006024834-A1 QUINAZOLINONE DERIVATIVES AND THEIR USE AS B-RAF INHIBITORS ASTRAZENECA AB (SE) 2006-03-09 WO disclosed
WO-2006003378-A1 AZINE-CARBOXAMIDES AS ANTI-CANCER AGENT ASTRAZENECA AB (SE) 2006-01-12 WO disclosed